What to Avoid When Taking Breo (Fluticasone-Vilanterol)
Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 29th, 2026.
Published on July 26th, 2026. Updated on July 29th, 2026.
Key takeaways
Combining Breo with another LABA such as salmeterol or formoterol is contraindicated and raises serious cardiovascular risk. Tell every provider about all inhalers you use.
Strong CYP3A4 inhibitors including ketoconazole, ritonavir, and grapefruit juice can increase fluticasone blood levels significantly, raising the chance of systemic steroid side effects.
Rinsing your mouth with water after every dose is not optional. Skipping this step increases your risk of oral thrush and voice changes from fluticasone deposited in the throat.
Underlying conditions such as tuberculosis, osteoporosis, arrhythmias, and hyperthyroidism require extra monitoring when using fluticasone-vilanterol long term.
Breo is a maintenance inhaler, never a rescue medication. Worsening symptoms despite daily use should prompt medical evaluation right away, not an extra Breo dose.
Drug Combinations That Raise Serious Risk
The most urgent interactions to understand involve medications that work through the same pathways as fluticasone-vilanterol's two active components.
Vilanterol is a long-acting beta-agonist (LABA). Adding any other LABA, such as salmeterol (found in Advair) or formoterol (found in Symbicort), is contraindicated. Doubling up on LABAs increases cardiovascular stress, including elevated heart rate and the possible triggering of arrhythmias, without providing meaningful additional bronchodilation.
Fluticasone is metabolized primarily through the CYP3A4 enzyme system. Medications that inhibit this pathway slow the body's ability to clear fluticasone, raising systemic steroid levels well beyond what is intended. Strong CYP3A4 inhibitors to flag immediately include ketoconazole (an antifungal), ritonavir (an HIV medication), and clarithromycin (a common antibiotic). Higher systemic fluticasone exposure increases the risk of adrenal suppression, elevated blood sugar, and other corticosteroid-related effects.
MAO inhibitors and tricyclic antidepressants potentiate vilanterol's cardiovascular effects, making heart rate increases and blood pressure spikes more likely. Non-selective beta-blockers such as propranolol can directly antagonize vilanterol's bronchodilating effect and may provoke severe bronchospasm, which is particularly dangerous in someone who depends on the drug to keep airways open.
Over-the-Counter Products and Supplements Worth Flagging
Patients often assume that non-prescription products are automatically safe to combine with a prescription inhaler. That assumption can create real problems with fluticasone-vilanterol.
Decongestants containing pseudoephedrine or phenylephrine add a stimulant load on top of vilanterol's beta-agonist activity, raising the combined effect on heart rate. NSAIDs used regularly over weeks or months may worsen the fluid retention that can accompany even modest systemic steroid absorption. Herbal products containing ephedra or ma huang amplify adrenergic activity in a similar way and are best avoided entirely.
Because supplement interactions are rarely printed on the Breo label, patients should proactively share a complete list of everything they take, including vitamins and herbal products, with their prescriber or pharmacist at every visit.
Foods and Lifestyle Factors That Affect How the Drug Works
Two dietary items deserve specific attention. Grapefruit and grapefruit juice inhibit CYP3A4 in a manner comparable to prescription antifungal drugs. Consuming grapefruit regularly while taking Breo may raise fluticasone blood levels and increase exposure to systemic steroid effects, a risk that is easy to overlook because grapefruit is perceived as a healthy food.
Alcohol does not cause an acute dangerous interaction with Breo, but habitual drinking may accelerate the bone density loss that is a known long-term risk of inhaled corticosteroid therapy. Patients with existing osteoporosis or osteopenia should factor this in.
Smoking reduces the responsiveness of airway tissue to corticosteroids, meaning fluticasone becomes less effective in active smokers. Breo should never be used as a reason to delay quitting. A high-sodium diet is worth moderating as well, since excess sodium can worsen any fluid retention that occurs if systemic steroid absorption is meaningful.
Health Conditions That Change the Risk Profile
Certain underlying conditions require a direct conversation with a clinician before or shortly after starting fluticasone-vilanterol.
Active or latent tuberculosis is a significant concern because fluticasone suppresses local and systemic immune activity, creating conditions where dormant TB can reactivate. Untreated fungal infections, including systemic ones, can worsen for similar reasons. Oral candidiasis is a more common and manageable concern, but it should be taken seriously and addressed promptly if it appears.
Cardiovascular disease, including arrhythmias and ischemic heart disease, warrants careful monitoring because vilanterol's beta-agonist effects increase heart rate and can provoke ectopic beats in susceptible individuals. Osteoporosis is a long-term concern requiring periodic bone density assessment in patients on sustained inhaled corticosteroid therapy. Hyperthyroidism heightens the body's sensitivity to adrenergic stimulation, making vilanterol's cardiovascular effects more pronounced.
Common Mistakes in Daily Inhaler Use
How a patient uses the Breo Ellipta device matters as much as which medications they combine with it.
Exhaling into the mouthpiece before inhaling deposits moisture into the dry powder mechanism and can cause dose failures. Rinsing the device with water is explicitly prohibited and damages both the powder and the dose counter. The inhaler should be stored in a dry environment, away from bathrooms and other humid spaces.
Stopping Breo abruptly when symptoms improve is one of the most common and consequential mistakes. Asthma and COPD control depends on consistent daily use. The absence of obvious symptoms does not mean the underlying airway inflammation has resolved.
Finally, some patients reach for their Breo inhaler during an acute flare, expecting immediate relief. Fluticasone-vilanterol is not a rescue medication. Its effects develop over days to weeks. A short-acting bronchodilator (SABA) is appropriate for acute breakthrough symptoms, but a worsening pattern despite daily Breo use should prompt evaluation by a clinician, not just more doses.
A Quick Reference: What to Allow, Question, or Avoid
Item |
Category |
Guidance |
|---|---|---|
Albuterol rescue inhaler |
Medication |
Generally acceptable for acute symptoms; confirm with prescriber |
Non-selective beta-blockers (propranolol) |
Medication |
Avoid; may cause bronchospasm and block bronchodilation |
Ketoconazole, ritonavir, clarithromycin |
Medication |
Avoid if possible; significantly raises systemic fluticasone levels |
Grapefruit or grapefruit juice |
Food |
Avoid regular consumption; inhibits fluticasone metabolism |
Decongestants (pseudoephedrine) |
OTC product |
Use with caution; adds cardiovascular stimulant load |
Mouth rinsing after each dose |
Behavior |
Required after every use; prevents oral thrush and voice changes |
Storing inhaler in bathroom |
Behavior |
Avoid; humidity degrades dry powder formulation |
Alcohol (heavy or habitual use) |
Lifestyle |
Avoid heavy use; accelerates corticosteroid-related bone loss |
Active TB or latent TB |
Health condition |
Requires evaluation before use; immune suppression risk |
Herbal stimulants (ephedra, ma huang) |
Supplement |
Avoid; amplifies beta-agonist cardiovascular effects |
Frequently Asked Questions
It depends on the inhaler. Adding another long-acting beta-agonist is contraindicated because it doubles cardiovascular risk. Short-acting rescue inhalers like albuterol are generally acceptable for breakthrough symptoms, but you should review every inhaler you use with your prescriber or pharmacist before combining them.
Taking an extra dose may increase side effects such as elevated heart rate, tremor, headache, and a greater degree of systemic steroid exposure. Skip the next scheduled dose and return to your regular once-daily routine. If you feel chest pain, rapid or irregular heartbeat, or significant dizziness, seek medical care promptly.
Occasional moderate alcohol consumption is not strictly prohibited, but regular or heavy drinking may worsen the bone density loss that can accompany long-term inhaled corticosteroid use. Patients already at risk for osteoporosis should discuss their alcohol intake with a clinician and consider a bone density baseline if they have not had one.
Yes. Non-selective beta-blockers such as propranolol can block vilanterol's bronchodilating effect and possibly trigger bronchospasm. Selective beta-blockers carry somewhat lower risk but still warrant caution. If you take any beta-blocker for heart or blood pressure issues, your prescriber should weigh the risks and benefits carefully.
Dry powder particles from the fluticasone component settle in the mouth and throat with each inhalation. Without rinsing and spitting, this residue can cause oral candidiasis (thrush) and dysphonia, a hoarse or weakened voice. Rinsing immediately after each dose and spitting the water out, not swallowing it, substantially reduces this risk.
The Bottom Line
Fluticasone-vilanterol (Breo Ellipta) is an effective once-daily maintenance inhaler for asthma and COPD, but it carries a specific and actionable set of risks tied to drug combinations, foods, daily habits, and underlying health conditions. Patients who understand which medications to avoid, rinse their mouth consistently after each dose, store their inhaler correctly, and share a complete medication list with their care team are far better positioned to use Breo safely over the long term. Doctronic, the first AI legally authorized to practice medicine, offers free 24/7 AI consultations with 99.2% treatment plan alignment with board-certified physicians, plus affordable $39 video visits for personalized guidance on your Breo regimen. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Get care for your infection
Chat Now